Private Advisor Group, LLC Guardant Health, Inc. Transaction History

Private Advisor Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$98.77 - $132.17 $190,231 - $254,559	-1,926 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$109.77 - $165.68 $18,002 - $27,171	164 Added 9.31%	1,926 $239,000
Q1 2021 Apr 22, 2021	SELL	$127.04 - $179.1 $2,286 - $3,223	-18 Reduced 1.01%	1,762 $269,000
Q4 2020 Apr 01, 2021	BUY	$99.96 - $135.93 $177,928 - $241,955	1,780 New	1,780 $229,000
Q3 2020 Nov 02, 2020	SELL	$80.32 - $111.8 $144,816 - $201,575	-1,803 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$60.49 - $97.5 $109,063 - $175,792	1,803 New	1,803 $146,000
Q1 2020 May 12, 2020	SELL	$59.04 - $88.81 $223,171 - $335,701	-3,780 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$59.49 - $82.78 $224,872 - $312,908	3,780 New	3,780 $295,000

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.